SANGAMO THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Additional Paid in Capital, Common Stock of $1.64 billion as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-05-14
- 2026-03-31: Additional Paid in Capital, Common Stock $1.64B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.61B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.59B.
- 2025-06-30: Additional Paid in Capital, Common Stock $1.57B.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2026-03-31 | $1.64B 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.61B 10-Q · filed 2026-05-14 |
| 2025-09-30 | $1.59B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.57B 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.54B 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.53B 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.52B 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.52B 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.52B 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.49B 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.49B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $1.48B 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.47B 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.45B 10-K · filed 2024-03-13 |
| 2022-09-30 | $1.42B 10-Q · filed 2022-11-03 |
| 2022-06-30 | $1.37B 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.34B 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.33B 10-K · filed 2023-02-23 |
| 2021-09-30 | $1.32B 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.31B 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.29B 10-Q · filed 2021-05-04 |
| 2020-12-31 | $1.27B 10-K · filed 2022-02-24 |
| 2020-09-30 | $1.26B 10-Q · filed 2020-11-04 |
| 2020-06-30 | $1.25B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.10B 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.09B 10-K · filed 2021-02-24 |
| 2019-09-30 | $1.08B 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.08B 10-Q · filed 2019-08-07 |
| 2019-03-31 | $934.11M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $929.63M 10-K · filed 2020-02-28 |
| 2018-09-30 | $923.16M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $918.20M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $696.43M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $682.81M 10-K · filed 2019-03-01 |
| 2017-09-30 | $668.33M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $663.38M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $582.60M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $576.38M 10-K · filed 2018-03-01 |
| 2016-09-30 | $574.34M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $571.55M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $564.37M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $560.99M 10-K · filed 2017-02-28 |
| 2015-09-30 | $558.04M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $545.24M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $540.64M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $534.52M 10-K · filed 2016-02-18 |
| 2014-09-30 | $533.63M 10-Q · filed 2014-10-28 |
| 2013-12-31 | $423.21M 10-K · filed 2015-02-25 |